Psychological intervention helps patients prevent gum disease
Researchers observed a reduction in dental plaque and bleeding, as well as an increase in dental cleanings among adults with moderate periodontal disease. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 19, 2019 Category: Consumer Health News Source Type: news

Mother-of-five describes horror of mysterious post-tubal ligation syndrome
Stacey Underwood, 36, got her tubes tied after having her fifth child. Shortly after, she developed night sweats, chills, mood swings and bleeding from post-tubal ligation syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - April 19, 2019 Category: Consumer Health News Source Type: news

Cardiac Risk of Noncardiac Surgery After PCI With DES Cardiac Risk of Noncardiac Surgery After PCI With DES
How prevalent are major adverse cardiac events and bleeding complications in patients undergoing noncardiac surgery after placement of second-generation drug-eluting stents?Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2019 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Novel Antiplatelet Agent May Not Increase Bleeding Risk Novel Antiplatelet Agent May Not Increase Bleeding Risk
Initial clinical results suggest that the new agent may be suitable for use with thrombolysis in acute ischemic stroke.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 18, 2019 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Experimental Blood Thinner May Help Prevent Stroke, Without the Bleeding Risk
THURSDAY, April 18, 2019 -- Researchers say an experimental stroke drug prevented blood clots without the typical side effect of blood thinners: increased bleeding risk. Bleeding is a common and potentially dangerous side effect of current... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 18, 2019 Category: General Medicine Source Type: news

Experimental Blood Thinner May Help Prevent Stroke, Without the Bleeding Risk
Title: Experimental Blood Thinner May Help Prevent Stroke, Without the Bleeding RiskCategory: Health NewsCreated: 4/18/2019 12:00:00 AMLast Editorial Review: 4/18/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 18, 2019 Category: Cardiology Source Type: news

AFib Patients Often Misjudge Stroke Risk vs OAC Bleeding Risk AFib Patients Often Misjudge Stroke Risk vs OAC Bleeding Risk
But is that okay? Patients may decide to take oral anticoagulants'without knowing the truth'about the size of their benefits and risks, neither of which measure up to perceptions, researchers say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

World Hemophilia Day: Sanofi Genzyme donation impacts patients across the globe
On World Hemophilia Day April 17th, the global bleeding disorders community unites to raise awareness and understanding of hemophilia and areas of unmet needs for patients. Hemophilia is a rare, genetic bleeding disorder in which the ability of a person's blood to clot is impaired, which can lead to bleeding episodes that can cause pain, irreversible joint damage, and life-threatening hemorrhages. (Source: World Pharma News)
Source: World Pharma News - April 17, 2019 Category: Pharmaceuticals Tags: Featured Sanofi Business and Industry Source Type: news

FDA Flips the Switch on Pelvic Mesh Manufacturers
After years of controversy surrounding the use of surgical mesh for transvaginal repair of pelvic organ prolapse (POP), FDA has ordered Boston Scientific and Coloplast to stop selling the mesh on the U.S. market immediately. The agency said the manufacturers have not demonstrated a reasonable assurance of safety and effectiveness for these devices, which is the premarket review standard that now applies to them since FDA decided they were high risk in 2016. “In order for these mesh devices to stay on the market, we determined that we needed evidence that they worked better than surgery without the use of ...
Source: MDDI - April 17, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

FDA To Boston Scientific: Stop Selling Pelvic Mesh Tied To Injuries In Women
WASHINGTON (AP) — U.S. health regulators on Tuesday halted sales of a type of surgical mesh used to repair pelvic conditions in women, following years of patients’ reports of injuries and complications from the implants. The Food and Drug Administration ordered the two remaining makers of the mesh — Boston Scientific and Coloplast — to stop selling it immediately, saying the companies failed to show the mesh is safe for long-term use. Several other major manufacturers, including Johnson & Johnson, previously stopped making the mesh. The FDA action does not apply to surgical mesh used to treat ot...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Boston Scientific FDA Source Type: news

Is an R & amp;D Race Driving the Surgical Robotics Market?
Robotic-assisted surgery has emerged with an attempt to overcome the limitations of traditional minimally invasive surgical procedures. With increasing competition, the way to gain market share in this quickly growing market is with innovative technology. This means R&D is at the forefront of this market, driving adoption, expanding applications, and leading to a market that will more than double in size by 2025. It’s been a steady trajectory since the first medical robot, Arthrobot, was developed in Canada in 1983 for use during orthopedic procedures1. Then, the first robotic-assisted procedure, neur...
Source: MDDI - April 16, 2019 Category: Medical Devices Authors: Yulia Sorokina and Jeff Wong Tags: R & D Orthopedics Source Type: news

Real-world-study-comparing-NOACs-in-AF-patients
Independent large real-world study comparing NOACs in AF-patientsA recently published large retrospective comparative study investigated stroke, bleeding and mortality risks in older US Medicare patients treated with commonly marketed oral anticoagulants for non-valvular atrial fibrillation1  Results of the real-world study showed that Pradaxa ® (dabigatran etexilate) was associated with a more favourable benefit-risk profile in comparison to both warfarin and rivaroxaban1Data from an earlier FDA-funded Medicare study published in 2015, which investigated cardiovascular, bleeding and mortality risks among patients...
Source: Boehringer Ingelheim Corporate News - April 15, 2019 Category: Research Source Type: news

Gene-based factor VIIa prevents bleeding episodes in animals with hemophilia
(Children's Hospital of Philadelphia) Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well. A study in animals may set the stage for a new therapy for a subset of patients with hemophilia who now develop antibodies to the standard maintenance treatment and then require on-demand 'bypass' therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: Low levels of 'bad cholesterol' may actually increase stroke risk
Recent findings suggest that women with low levels of low-density lipoprotein cholesterol — or 'bad cholesterol' — have a heightened bleeding stroke risk. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2019 Category: Consumer Health News Tags: Cholesterol Source Type: news

Cochrane's 30 under 30: Ndi Euphrasia Ebai-Atuh
Cochrane is made up of  13,000 members and over 50,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.  Many  of our contributors are young people working with Cochrane ...
Source: Cochrane News and Events - April 12, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Conformal Medical launches LAA seal study
Conformal Medical said yesterday that it launched an investigational device exemption trial for a device designed to seal off the heart’s left atrial appendage to help prevent stroke in atrial fibrillation patients. Nashua, N.H.-based Conformal’s device is designed to adapt to the each patient’s individual physiology, to be easier to implant with less imaging and without general anesthesia. The 45-patient, single-arm study is designed to evaluate the device’s performance, with an estimated primary completion date of April 2020 and a final completion date of June 2025, according to ClinicalTrials.gov...
Source: Mass Device - April 10, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Implants Clinical Trials Featured Conformal Medical Source Type: news

Vaginal Bleeding in a Postmenopausal Woman
The 62-year-old describes lower abdominal “pressure” and using 2 pads/day; she reports a recent UTI. Review lab results and CT scan. What’s your diagnosis? (Source: ConsultantLive)
Source: ConsultantLive - April 10, 2019 Category: Internal Medicine Authors: Brady Pregerson, MD Tags: Women ' s Health Source Type: news

Women often keep impact of menstrual pain, bleeding to themselves
Many women who suffer from menstrual symptoms like pain and heavy bleeding don't tell their families or doctors about it even when it interferes with their ability to keep up with daily routines, a Dutch study suggests. (Source: Reuters: Health)
Source: Reuters: Health - April 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Regular aspirin use linked to 50% increased risk of MAJOR bleeding episodes, warn researchers
(Natural News) You might have heard that taking aspirin on a daily basis can help prevent heart attacks, but is it really such a good idea to regularly take medication if nothing is wrong with you? According to a new study published in the Journal of the American Medical Association, the answer to that is... (Source: NaturalNews.com)
Source: NaturalNews.com - April 5, 2019 Category: Consumer Health News Source Type: news

Endoscopic Clip Closure After Large Polyp Resection in Right Colon Reduces Bleeding Endoscopic Clip Closure After Large Polyp Resection in Right Colon Reduces Bleeding
Endoscopic clip closure after resection of large sessile polyps in the proximal colon reduced the risk of post-procedure bleeding in a multicenter randomized trial, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 4, 2019 Category: Surgery Tags: Gastroenterology News Source Type: news

Medical child abuse: an unusual "source" of vaginal bleeding - Kelley DM, Curran KA.
BACKGROUND: Medical child abuse (MCA) is challenging to diagnose. While young children are often affected, adolescents can be victims through caregiver coercion. Presentation is highly variable. Diagnosis is essential due to high associated morbidity and m... (Source: SafetyLit)
Source: SafetyLit - April 4, 2019 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

ELIMINATE-AF: Edoxaban Viable Alternative to VKA in AF Ablation ELIMINATE-AF: Edoxaban Viable Alternative to VKA in AF Ablation
Oral anticoagulant edoxaban was as efficacious and safe as a VKA for use in catheter ablation of atrial fibrillation, an exploratory trial shows. The major composite outcome and bleeding were similar.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 3, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Effect of sugar-free chewing gum on plaque and gingivitis among 14 –15-year-old school children: A randomized controlled trial
Year: 2019  | Volume : 30  | Issue : 1  | Page : 61-66Aim: The aim of the study was to find out the effect of sugar-free chewing gums (xylitol and sorbitol) on plaque and gingivitis among 14 –15-year-old school children.Materials and Methods: A single center, double-blind, randomized controlled trial was conducted on 14 –15-year-old children. Sample size was determined to be 48. Participants were randomly allocated to test group (xylitol [n = 12], sorbitol [n = 12]) and control group (no gum,n = 24). Duration of the study was 14 days. Baseline assessment of plaque, gingival, a...
Source: Dental Technology Blog - April 2, 2019 Category: Dentistry Source Type: news

Channel Medsystems wins PMA for Cerene cryoablation device
Channel Medsystems last week won pre-market approval from the FDA for its Cerene endometrial cryoablation device, starting the clock on a mandatory three-year post-approval study. Cerene, which is designed to treat heavy but benign bleeding in premenopausal women for whom child bearing is complete, won CE Mark approval in the European Union in June 2017. The PMA granted March 28 is based on 12-month data from the 242-patient Clarity pivotal trial, which must now be extended for another 36 months, according to the FDA. Emeryville, Calif.-based Channel Medsystems must follow at least 85% of Clarity patients out to ...
Source: Mass Device - April 2, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Food & Drug Administration (FDA) Regulatory/Compliance Women's Health Boston Scientific Channel Medsystems Source Type: news

Minnesota health plans, flush with cash, may give rebates to consumers
Minnesota's nonprofit health insurers reported a surge in income in 2018 from selling plans to individuals — a sign of strength in a market that just a few years ago was bleeding red ink. The Star Tribune has a report on the latest financial results from insurance providers, which in aggregate reported their biggest positive operating margin since 2011. That's just a few years after reporting such big losses on the individual coverage market that many providers were driven out altogether and consumers… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 2, 2019 Category: Health Management Authors: Mark Reilly Source Type: news

Minnesota health plans, flush with cash, may give rebates to consumers
Minnesota's nonprofit health insurers reported a surge in income in 2018 from selling plans to individuals — a sign of strength in a market that just a few years ago was bleeding red ink. The Star Tribune has a report on the latest financial results from insurance providers, which in aggregate reported their biggest positive operating margin since 2011. That's just a few years after reporting such big losses on the individual coverage market that many providers were driven out altogether and consumers… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 2, 2019 Category: Biotechnology Authors: Mark Reilly Source Type: news

Health Tip: Daily Aspirin Therapy
-- Aspirin can prevent heart attacks and strokes by lowering the clotting action of the blood's platelets. However, preventing blood from clotting can also cause stomach or brain bleeding, kidney failure and other kinds of strokes, the U.S. Food... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 2, 2019 Category: General Medicine Source Type: news

School nurses on the front lines of medicine: the approach to a student with severe traumatic bleeding - Erdman MO, Chardavoyne P, Olympia RP.
With the continued threat of mass casualty incidents in schools and surrounding communities, it is essential for school nurses to be knowledgeable regarding the recognition of hemorrhagic shock due to massive bleeding and the acute management of these vict... (Source: SafetyLit)
Source: SafetyLit - March 30, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Magnetic System Aims to Make Bariatric Surgery Less Invasive
A recent study concluded that a "first-of-its-kind" magnetic surgical system allows a safe, reproducible, incision-less technique for port-less intraabdominal mobilization. The Magnetic Surgical System, developed by Levita Magnetics, is so unlike current technologies that FDA had to create a whole new category for it when approving it for use, according to Alberto Rodriguez-Navarro, MD, CEO and founder of Levita Magnetics, in an interview with MD+DI. The system consists of an external magnet placed on the skin that controls a shaftless detachable grasper. It enables surgeons to move instruments without the constr...
Source: MDDI - March 29, 2019 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news

Can a protein in cord blood predict risk of death, cerebral palsy in preterm infants?
(University of Illinois at Chicago) Researchers at the University of Illinois at Chicago have found that some preterm babies born without haptoglobin, a protein in blood cells, have higher odds of brain bleeding, cerebral palsy and death. Their findings suggest that the absence of the protein could serve as a potential biomarker indicating a need for increased monitoring or other preventive interventions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2019 Category: International Medicine & Public Health Source Type: news

Bayer loses bid to toss some claims in Essure class action suit
A federal judge in Philadelphia will allow six women who are suing Bayer (ETR:BAYN) over its Essure sterilization implant to proceed with their personal injury claims and three others to pursue their breach-of-warranty claims. One woman who became pregnant following implantation with Essure will be able to pursue her claim that Bayer fraudulently concealed the risk of pregnancy, the judge ruled. Bayer had filed a motion for partial summary judgment on all 12 plaintiffs’ claims in the class action suit, citing statutes of limitations. Judge John Padova of the Eastern District of Pennsylvania granted Bayer’s moti...
Source: Mass Device - March 28, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Featured Gynecological Implants Legal News News Well Women's Health Bayer Source Type: news

Bayer, J & J Settle Thousands of U.S. Xarelto Lawsuits for $775 Mln Bayer, J & J Settle Thousands of U.S. Xarelto Lawsuits for $775 Mln
Bayer AG and Johnson& Johnson have agreed to settle more than 25,000 U.S. lawsuits alleging that their blockbuster blood thinner Xarelto (rivaroxaban) aused unstoppable and in some cases fatal bleeding for a total of $775 million, court documents on Monday showed.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 27, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Johnson & Johnson and Bayer settle Xarelto lawsuits for $775 million
Johnson& Johnson and Bayer agreed Monday to pay $775 million to settle almost 25,000 lawsuits in connection to blood thinner Xarelto. Each company will pay 50 percent of the settlement, according to The New York Times. The payment ends both state and federal cases — the New Brunswick, New Jersey-based Johnson& Johnson (NYSE: JNJ) jointly markets Xarelto with Bayer, which is based in Germany. Patients sued both companies, which failed to issue warnings regarding possible fatal bleeding episodes… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 26, 2019 Category: American Health Authors: Gina Hall Source Type: news

Woman, 22, slams the NHS after she was denied a smear test
Demi-Lee Stewart, from Glasgow, is still three years away from the Government's smear testing threshold of 25. She has been suffering bleeding between periods - a sign of cervical cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2019 Category: Consumer Health News Source Type: news

Johnson & Johnson and Bayer settle Xarelto lawsuits for $775 million
Johnson& Johnson and Bayer agreed Monday to pay $775 million to settle almost 25,000 lawsuits in connection to blood thinner Xarelto. Each company will pay 50 percent of the settlement, according to The New York Times. The payment ends both state and federal cases — the New Brunswick, New Jersey-based Johnson& Johnson (NYSE: JNJ) jointly markets Xarelto with Bayer, which is based in Germany. Patients sued both companies, which failed to issue warnings regarding possible fatal bleeding episodes… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 25, 2019 Category: Health Management Authors: Gina Hall Source Type: news

Bayer and Johnson & Johnson Settle Lawsuits Over Xarelto, a Blood Thinner, for $775 Million
The settlement resolves about 25,000 lawsuits, which claimed the companies failed to warn about deadly bleeding episodes caused by the drug. (Source: NYT Health)
Source: NYT Health - March 25, 2019 Category: Consumer Health News Authors: KATIE THOMAS Tags: Xarelto Drugs (Pharmaceuticals) Bayer AG Suits and Litigation (Civil) Johnson & Food and Drug Administration your-feed-science Source Type: news

Cruise Passengers Recall Helicopter Rescues
STAVANGER, Norway (AP) — Rodney Horgen recalled the moment he thought he was facing the end: when a huge wave crashed through the Viking Sky cruise ship's glass doors and swept his wife 30 feet across the floor. Horgen, 62, of Minnesota, was visiting Norway on a dream pilgrimage to his ancestral homeland when the luxury cruise quickly turned into a nightmare. The Viking Sky was carrying 1,373 passengers and crew, going from Norway's Arctic north to the southern city of Stavanger when it had engine trouble along Norway's rough, frigid western coast. Struggling in heavy seas to avoid being dashed on the rocky coast, th...
Source: JEMS: Journal of Emergency Medical Services News - March 25, 2019 Category: Emergency Medicine Tags: International Major Incidents News Source Type: news

Aspirin: Have the New Guidelines Changed What You Should Do?
For many people without evidence of cardiovascular disease, less will be more – with the benefit of aspirin just not worth the risk and inconvenience – and that is particularly true for those older than 70 years or with an increased risk of bleeding. And that fits just fine with the new guidelines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 21, 2019 Category: Pharmaceuticals Authors: Harlan Krumholz, Contributor Source Type: news

ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
WEDNESDAY, March 20, 2019 -- For patients with atrial fibrillation (AF), catheter ablation does not significantly reduce the risk for death, disabling stroke, serious bleeding, or cardiac arrest, but it does improve quality of life versus medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 20, 2019 Category: Pharmaceuticals Source Type: news

Study: OK to Stop Aspirin 3 Months After Stent
Patients who get drug-eluting stents to open a blocked artery can stop taking aspirin after just three months, instead of the typical full year, and lower their risk of bleeding, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - March 19, 2019 Category: Consumer Health News Source Type: news

Mother, 38, claims she saw doctors over 20 TIMES before an ovarian cancer diagnosis
Claire Thompson visited her GP and A&E around 20 times over 18 months with severe heavy bleeding, She underwent a life-saving hysterectomy in 2016 when doctors discovered cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2019 Category: Consumer Health News Source Type: news

A Better Cardiac Pump for People With Heart Failure?
TUESDAY, March 19, 2019 -- A new version of an implantable heart pump could cut the risk of blood clots, bleeding and stroke in patients with advanced heart failure, according to a study funded by the device's maker. The study included more than a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 19, 2019 Category: General Medicine Source Type: news

Daily Low-Dose Aspirin No Longer Recommended by Doctors, if You ’ re Healthy
New guidelines suggest the risk of bleeding outweighs the heart benefits among healthy adults who take low-dose aspirin. (Source: NYT Health)
Source: NYT Health - March 18, 2019 Category: Consumer Health News Authors: LAURA M. HOLSON Tags: Aspirin Heart American College of Cardiology American Heart Assn Michos, Dr. Erin Source Type: news

Docs Back Off Aspirin to Prevent 1st Heart Attack
The American College of Cardiology and the American Heart Association agree that for older adults at low heart risk, the chance of bleeding that comes with daily low-dose aspirin outweighs any heart benefit. (Source: WebMD Health)
Source: WebMD Health - March 18, 2019 Category: Consumer Health News Source Type: news

ACC 2019: Abbott touts reduced stroke, bleeding and pump-clotting in HeartMate 3 trial
Abbott (NYSE:ABT) yesterday presented data from a new trial of its HeartMate 3 left ventricular assist device, touting a reduced rate of strokes, pump-related blood clots and bleeding episodes at two years as compared with the previous generation HeartMate II. Data in the trial was presented at the American College of Cardiology’s 68th Annual Scientific Session 2019 in New Orleans and published simultaneously in the New England Journal of Medicine, the Chicago-area medical device company said. Abbott touted its HeartMate 3 as the first implantable mechanical pump using fully magnetic levitation technology, makin...
Source: Mass Device - March 18, 2019 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Featured Abbott Source Type: news

8 Science-Backed Ways to Prevent Heart Attacks, According to New Guidelines
Experts have issued a new set of guidelines on the best ways to prevent first heart attacks, strokes and heart failure — and for the first time, they focus squarely on the patient. The new guidelines recognize how doctors can support people to not only address their medical risk factors, but also to change their behaviors and lifestyles in order to reduce their risk. The latest revisions to the guidelines, issued by the American College of Cardiology (ACC) and the American Heart Association (AHA), were announced at the annual meeting of the ACC. They are intended to help doctors figure out a patient’s risk of h...
Source: TIME: Health - March 18, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Heart Disease Source Type: news

Mother dies of cervical cancer after missing just ONE smear test 
Carly Gorst, of Speke, Liverpool, discovered she had a four-inch tumour in her cervix in December 2017 after she began bleeding heavily. She endured surgery, chemo and radiotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2019 Category: Consumer Health News Source Type: news

Daily Aspirin No Longer Recommended To Prevent Heart Attacks In Older Adults
(CNN) — If you’re a healthy older adult looking for ways to reduce your risk of heart attack and stroke, don’t turn to that age-old standby: daily low-dose aspirin. It’s no longer recommended as a preventative for older adults who don’t have a high risk or existing heart disease, according to guidelines announced Sunday by the American College of Cardiology and the American Heart Association. “For the most part, we are now much better at treating risk factors such as hypertension, diabetes and especially high cholesterol,” said North Carolina cardiologist Dr. Kevin Campbell, who wa...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news

Stopping aspirin three months after stenting does not increase risk of death
(American College of Cardiology) Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor -- clopidogrel, prasugrel or ticagrelor -- did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. Furthermore, patients who stopped taking aspirin after three months had a significantly lower rate of bleeding. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news

AUGUSTUS Backs Apixaban'Double Therapy' in Most AF Post-ACS, PCI AUGUSTUS Backs Apixaban'Double Therapy' in Most AF Post-ACS, PCI
The most safe and effective antithrombotic regimen may involve neither warfarin nor aspirin, suggested a trial that might allay bleeding-risk concerns in a tough-to-treat atrial fibrillation population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 17, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news